Paravertebral Block, an Adjunct to General Anaesthesia for Breast Surgery?

NCT ID: NCT00547989

Last Updated: 2014-06-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

46 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-10-31

Study Completion Date

2011-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aim is to study if a paravertebral block as an adjunct to general anesthesia is a suitable technique for extended, one sided, breast surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Usually breast tumour surgery in the Academic Hospital Maastricht is performed under general anaesthesia. Perioperative pain management consists of paracetamol and naproxen preoperatively, opioids during surgery and local wound infiltration at the end of surgery with 10cc Bupivacaine 0.25%. Postoperative pain management consists of paracetamol, occasionally combined with Naproxen, and if necessary Piritramide 0.2 mg/kg i.m.

Alternatively there is the possibility to perform breast surgery under a thoracic paravertebral block (PVB) with or without general anesthesia.

A PVB according to Eason and Wyatt (1) can be performed preoperatively with insertion of an end-hole catheter T3-T4. With this technique we expect a better pain relief postoperatively.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

control

Group Type ACTIVE_COMPARATOR

standard anaesthesia (bupivacaine)

Intervention Type DRUG

Local infiltration with bupivacaine and Piritramide and Paracetamol as postoperative analgesic, and ondansetron as required

2

PVB with ropivacaine and postoperative pump 5ml/h

Group Type EXPERIMENTAL

additional pvb (ropivacaine) and elastomeric disposable infusion pump

Intervention Type DRUG

Patients in group 2 will receive PVB with ropivacaine and postoperative pump 5ml/h.

Experimental 1

PVB with ropivacaine, 10 patients included but not analysed

Group Type EXPERIMENTAL

additional pvb (ropivacaine)

Intervention Type DRUG

Patients in group 1 will receive PVB with ropivacaine

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

standard anaesthesia (bupivacaine)

Local infiltration with bupivacaine and Piritramide and Paracetamol as postoperative analgesic, and ondansetron as required

Intervention Type DRUG

additional pvb (ropivacaine) and elastomeric disposable infusion pump

Patients in group 2 will receive PVB with ropivacaine and postoperative pump 5ml/h.

Intervention Type DRUG

additional pvb (ropivacaine)

Patients in group 1 will receive PVB with ropivacaine

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Extended mamma surgery one-sided
* ASA class I and II

Exclusion Criteria

* All contra indications for local anaesthesia
* Coagulation disorders
* Infection
* Allergic reactions
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Maastricht University Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Esther Bouman, MD

Role: PRINCIPAL_INVESTIGATOR

azM

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital

Maastricht, , Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MEC 05-105.5

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PVB vs PECS Block in Breast Surgery
NCT02677571 COMPLETED NA